| Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study D Kumar, MG Michaels, MI Morris, M Green, RK Avery, C Liu, ... The Lancet infectious diseases 10 (8), 521-526, 2010 | 398 | 2010 |
| Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites S Kappe, T Bruderer, S Gantt, H Fujioka, V Nussenzweig, R Ménard The Journal of cell biology 147 (5), 937-944, 1999 | 352 | 1999 |
| Proteasome Inhibitors Block Development ofPlasmodium spp SM Gantt, JM Myung, MRS Briones, WD Li, EJ Corey, S Omura, ... Antimicrobial agents and chemotherapy 42 (10), 2731-2738, 1998 | 215 | 1998 |
| Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection S Gantt, F Dionne, FK Kozak, O Goshen, DM Goldfarb, AH Park, ... JAMA pediatrics 170 (12), 1173-1180, 2016 | 192 | 2016 |
| Real-time detection and monitoring of loop mediated amplification (LAMP) reaction using self-quenching and de-quenching fluorogenic probes VJ Gadkar, DM Goldfarb, S Gantt, PAG Tilley Scientific reports 8 (1), 5548, 2018 | 191 | 2018 |
| Antibodies against Thrombospondin-Related Anonymous Protein Do Not Inhibit Plasmodium Sporozoite Infectivity In Vivo S Gantt, C Persson, K Rose, AJ Birkett, R Abagyan, V Nussenzweig Infection and immunity 68 (6), 3667-3673, 2000 | 138 | 2000 |
| Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment S Gantt, C Casper Current opinion in infectious diseases 24 (4), 295-301, 2011 | 133 | 2011 |
| Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology V Thathy, H Fujioka, S Gantt, R Nussenzweig, V Nussenzweig, R Ménard The EMBO journal, 2002 | 106 | 2002 |
| Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age EJ Anderson, CB Creech, V Berthaud, A Piramzadian, KA Johnson, ... New England Journal of Medicine 387 (18), 1673-1687, 2022 | 100 | 2022 |
| The role of myeloid-derived suppressor cells in immune ontogeny S Gantt, A Gervassi, H Jaspan, H Horton Frontiers in immunology 5, 387, 2014 | 97 | 2014 |
| Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses A Gervassi, N Lejarcegui, S Dross, A Jacobson, G Itaya, E Kidzeru, ... PloS one 9 (9), e107816, 2014 | 96 | 2014 |
| The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro S Gantt, J Carlsson, M Ikoma, E Gachelet, M Gray, AP Geballe, L Corey, ... Antimicrobial agents and chemotherapy 55 (6), 2696-2703, 2011 | 87 | 2011 |
| Importance of COVID-19 vaccine efficacy in older age groups M Sadarangani, BA Raya, JM Conway, SA Iyaniwura, RC Falcao, C Colijn, ... Vaccine 39 (15), 2020-2023, 2021 | 83 | 2021 |
| Prospective characterization of the risk factors for transmission and symptoms of primary human herpesvirus infections among Ugandan infants S Gantt, J Orem, EM Krantz, RA Morrow, S Selke, ML Huang, JT Schiffer, ... The Journal of infectious diseases 214 (1), 36-44, 2016 | 78 | 2016 |
| Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG SM Gantt, P Clavijo, X Bai, JD Esko, P Sinnis Journal of Biological Chemistry 272 (31), 19205-19213, 1997 | 78 | 1997 |
| Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children S Gantt, A Kakuru, A Wald, V Walusansa, L Corey, C Casper, J Orem Pediatric blood & cancer 54 (5), 670-674, 2010 | 74 | 2010 |
| Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention S Gantt, C Casper, RF Ambinder Current opinion in oncology 25 (5), 495-502, 2013 | 72 | 2013 |
| Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells BT Mayer, EM Krantz, D Swan, J Ferrenberg, K Simmons, S Selke, ... Journal of virology 91 (12), 10.1128/jvi. 00380-17, 2017 | 68 | 2017 |
| Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial T Vesikari, JM Langley, N Segall, BJ Ward, C Cooper, G Poliquin, B Smith, ... The Lancet Infectious Diseases 21 (9), 1271-1281, 2021 | 65 | 2021 |
| Intermittent preventive treatment using artemisinin‐based combination therapy reduces malaria morbidity among school‐aged children in Mali B Barger, H Maiga, OB Traore, M Tekete, I Tembine, A Dara, ZI Traore, ... Tropical Medicine & International Health 14 (7), 784-791, 2009 | 64 | 2009 |
Corey Casper, MD MPHPresident and Chief Executive Officer, Access to Advanced Health InstituteVerified email at aahi.org
